Title: VanArsdale T, et al. Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment. Clin Cancer Res. 2015 Jul 1;21(13):2905-10.
1374639-75-4
1211443-80-9
1374639-79-8
1977495-97-8
2097938-59-3
1374639-78-7
15476-49-0 | 2-Amino-3-(1-carboxyethyldisulfanyl)propanoic acid | AA01E6PI
40982-19-2 | 2-Chloro-5-(1-chloroethyl)-1,3-thiazole | AA01E6YK | MFCD20628166
30461-82-6 | Blood group A hexasaccharide type II | AA01E74Y
2126177-82-8 | ethyl 2-bromo-1-phenylcyclopropane-1-carboxylate | AA01E79J | MFCD31381236
2089257-09-8 | (4-chlorothiophen-3-yl)methanamine | AA01E7CC | MFCD30724120
2126144-51-0 | (1S)-1-(4-methoxy-3-methylphenyl)ethan-1-amine hydrochloride | AA01E7FH | MFCD24426266
2138809-91-1 | 6-[2-(3,4-dichlorophenoxy)-1-hydroxyethylidene]-3-hydroxycyclohexa-2,4-dien-1-one | AA01E7IQ | MFCD31381486
1239464-79-9 | 2-(isoquinolin-5-yl)acetic acid hydrochloride | AA01E7LM | MFCD30730458
2095396-36-2 | (1s,3s)-1-amino-3-hydroxycyclobutane-1-carboxylic acid hydrochloride | AA01E7OB | MFCD30734016
488-38-0 | D-Glycero-d-talo-heptitol | AA01E7TB | MFCD07778590